v3.26.1
Segment Reporting
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting Segment Reporting
The Company conducts business as a single operating and reportable segment, focusing on the business of performance beauty by delivering breakthrough products to the cash-pay aesthetic market. Under this organizational structure, the Chief Executive Officer, serving as the CODM, assesses performance and manages the Company’s operations as one integrated business. The identification of a single operating and reportable segment is consistent with the management approach in that the CODM regularly reviews consolidated financial information for the purpose of assessing performance and allocating resources.
The CODM regularly reviews (i) net revenues, (ii) gross profit, (iii) operating profit or loss and (iv) net income or loss and uses net income or loss as the key measure of segment profit or loss when allocating resources and assessing performance. The CODM compares net income or loss in prior periods with that of the current period, evaluates actual results against budget and forecast, identifies relevant business factors and trends, and evaluates the achievements of the Company’s established strategic goals. In April 2025, the Company launched Evolysse® Form and Evolysse® Smooth in the United States, and, in May 2026, the Company launched four Evolysse® products in Europe. As such, segment product net revenue has been recast in connection with the launch of Evolysse®. The table below presents selected financial information of the
Company’s single reportable segment regularly provided to and reviewed by the CODM and a reconciliation of segment net loss to consolidated net loss as computed under U.S. GAAP:
Three Months Ended June 30,Six Months Ended
June 30,
2026202520262025
Revenue:
Jeuveau®
$74,456 $58,968 $140,477 $127,042 
Evolysse®
8,894 9,731 15,620 9,731 
Total product revenue, net83,350 68,699 156,097 136,773 
Service revenue734 688 1,124 1,136 
Total net revenues84,084 69,387 157,221 137,909 
Less:
Cost of goods sold
26,904 24,067 51,144 45,934 
Gross profit57,180 45,320 106,077 91,975 
Less:
Research and development
1,892 1,837 4,132 4,049 
Selling, general and administrative
57,052 56,675 109,033 113,315 
Depreciation and amortization
1,529 932 3,067 1,756 
Interest income
(296)(479)(581)(1,189)
Interest expense
4,172 7,207 8,147 11,622 
Income tax (benefit) expense(154)53 102 125 
Other segment items(1)
1,037 (3,763)903 (1,669)
Segment net loss$(8,052)$(17,142)$(18,726)$(36,034)
Reconciliation of profit and loss (Segment net loss/profit):
Adjustments and reconciling items
— — — — 
Consolidated net loss$(8,052)$(17,142)$(18,726)$(36,034)
(1) Other segment items include revaluation of contingent royalty obligation payable to Evolus Founders and Other (income) expense, net.
Information regarding segment assets provided to the CODM is consistent with that reported in the accompanying condensed consolidated balance sheets with particular emphasis on the Company’s available liquidity and working capital, including its cash and cash equivalents, accounts receivables, inventory and current liabilities.